Kiora Pharmaceuticals (KPRX) Earnings Date & Reports
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more
KPRX is expected to report earnings to fall 26.47% to -25 cents per share on March 30
Q4'26
Est.
$-0.25
Q2'26
Beat
by $0.17
Q1'26
Missed
by $0.09
Q4'25
Missed
by $1.50
Q3'25
Beat
by $0.07
The last earnings report on August 07 showed earnings per share of -34 cents, beating the estimate of -50 cents. With 300.00 shares outstanding, the current market capitalization sits at 10.57M.